Tympanic Thermometers Accuracy

Sponsor
Istituto Ortopedico Rizzoli (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06103604
Collaborator
(none)
1,100
7
24
157.1
6.6

Study Details

Study Description

Brief Summary

The aim of the present study is to evaluate the measurement precision and accuracy of the third-generation tympanic thermometer in relation to the measurement modalities considered gold standard. The evaluation of the instrument will be conducted in relation to the different calibration times of the tympanic thermometer, the level of re-training of healthcare personnel in the use of the instrument and the adult and paediatric population subjected to the measurement. Finally, the diagnostic capacity of the instrument in correctly identifying states of hypothermia and febrile elevations will be assessed.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: latest generation tympanic thermometer

Detailed Description

The temperature measurement will be taken on each patient enrolled at a single time by the caregiver for that patient. As the measurements do not depend on which side they are taken, the most convenient side will be chosen. Each patient will only be included once

The research nurse will record the core temperature from the monitor on the CRF and, within the next 5 minutes, take the peripheral temperature with the tympanic thermometer three times in a row, recording all three values on the CRF. Subsequently a second operator will always take the temperature 3 times within 5 minutes of the gold standard measurement. The gold standard (reference tests), as indicated in the literature, can be either the thermometer inserted in the probe placed in the pulmonary artery, or the thermometer inserted in the bladder catheter or oesophageal probe, or directly a rectal thermometer.

Only the first tympanic measurement will then be used to assess accuracy against the gold standard. The other measurements above will only be evaluated for inter and intra reliability. The unit under study is therefore the individual patient at a precise point in time

Study Design

Study Type:
Observational
Anticipated Enrollment :
1100 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
The Diagnostic Accuracy and Precision of the Latest Generation Tympanic Thermometers in the Adult and Paediatric Population: Multicentre Cross-sectional Study
Anticipated Study Start Date :
Jan 1, 2024
Anticipated Primary Completion Date :
Nov 30, 2025
Anticipated Study Completion Date :
Dec 30, 2025

Arms and Interventions

Arm Intervention/Treatment
in-patients requiring temperature monitoring

The patient at any age whose core temperature is monitored during hospitalisation

Diagnostic Test: latest generation tympanic thermometer
The patient whose core temperature is monitored during hospitalisation has his temperature at tympanic level taken once during the stay. The research nurse will record the core temperature from the monitor on the CRF and, within the next 5 minutes, take the peripheral temperature with the tympanic thermometer three times in a row, recording all three values on the CRF. Subsequently a second operator will always take the temperature 3 times within 5 minutes of the gold standard measurement. Only the first tympanic measurement will then be used to assess accuracy against the gold standard.

Outcome Measures

Primary Outcome Measures

  1. Measure of Agreement [The temperature measurement will be taken on each patient enrolled up to 2 weeks]

    Measure of Agreement between the thermometer and the gold standard to be assessed by the Bland and Altman method.

Secondary Outcome Measures

  1. accuracy [The temperature measurement will be taken on each patient enrolled up to 2 weeks]

    sensitivity, specificity, predictive values, likelihood ratios

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Months and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Paediatric patients over the age of 4 months

  • adults admitted to intensive care and resuscitation

  • undergoing surgery who by current practice undergo invasive core temperature measurement

Exclusion Criteria:
  • Patients with bilateral auricular inflammatory problems,

  • patients who will not use the gold standard for clinical reasons,

  • patients or legal guardians who do not consent to participate in the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 ASO Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo Alessandria Italy 15121
2 Istituto Ortopedico Rizzoli Bologna Italy 40136
3 Policlinico di S.Orsola Azienda Ospedaliero-Universitaria di Bologna Bologna Italy 40138
4 Azienda Ospedaliera Universitaria Meyer Istituto di Ricovero e Cura a Carattere Scientifico Firenze Italy 50139
5 Fondazione IRCCS Policlinico San Matteo Pavia Italy 27100
6 APSS Trento Trento Italy 38123
7 Azienda Ospedaliera Universitaria Integrata di Verona Verona Italy 37126

Sponsors and Collaborators

  • Istituto Ortopedico Rizzoli

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Istituto Ortopedico Rizzoli
ClinicalTrials.gov Identifier:
NCT06103604
Other Study ID Numbers:
  • 507/2023/Oss/IOR
First Posted:
Oct 27, 2023
Last Update Posted:
Oct 27, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Istituto Ortopedico Rizzoli

Study Results

No Results Posted as of Oct 27, 2023